loading

Dear Colleagues,

I am delighted to reach out to you through this October 2014 edition of Oviya MedSafe’s newsletter, which I write from Mumbai where I am now to take part in the DIA 2014 9th Annual India Conference: The Future of Indian Health Care: Patients, Access and Innovation, between 16th and 18th October 2014. It is my great pleasure to catch up with pharmacovigilance colleagues and a learning experience to listen to the different perspectives of the attendees on various topics.

The month of September 2014 saw Oviya MedSafe attaining yet another milestone: An article titled ‘The Role of Clinical Pharmacists in Pharmacovigilance: Some Thoughts From India’ authored by my colleagues Subash and Ganesan along with me, was published in the September 2014 edition (Issue 45) of PIPELINE – the Journal of the Pharmaceutical Information & Pharmacovigilance Association (PIPA), UK. Ever since the article got published, we have been receiving quite a lot of appreciation from the pharmacovigilance industry, fraternity of the pharmacology academia and the hospital-based healthcare professionals alike. PIPA members can read this article by clicking on http://www.pipaonline.org/Pipeline-Journal, after logging in to their online account.

As indicated in our last month’s newsletter, I am glad to reiterate that I will be speaking in two co-located international conferences organized by the OMICS group at Hyderabad International Convention Centre, Hyderabad, India between 27-Oct-2014 and 29-Oct-2014.

Of these, the 3rd International Conference and Exhibition on Pharmacovigilance & Cinical Trials 2014 will have me as one of the Keynote Speakers, with the title of my address being ‘Hosted Pharmacovigilance Software Databases – The Emerging Solution’. This will tentatively be the opening session of the conference starting at 09:00 hours IST on 27-Oct-2014.

In the 3rd International Conference and Exhibition on Biowaivers, Biologics and Biosimilars 2014, I will talk on ‘Pharmacovigilance of Biosimilars – Challenges & Possible Solutions’. This session is tentatively scheduled at 14:40 hours IST on 29-Oct-2014.

I hope I will be able to meet many friends from the industry and academia during these conferences. I am also keen to hear from you your thoughts on what you think should be covered in my talks on the above-mentioned topics, so that I can touch upon them in my presentations.

Looking forward to connecting with you in November 2014 with more exciting news,

With thanks & regards,
Dr J Vijay Venkatraman
MBBS, F. Diab., MBA., FPIPA (UK)

Managing Director & CEO,
Oviya MedSafe
Pharmacovigilance Consulting & Drug Safety Services
Coimbatore, India & London, UK

India Office: +91-422-2444442
UK Office: +44-8452-733839

Website: www.oviyamedsafe.com
Facebook: www.facebook.com/OviyaMedSafe
Twitter: www.twitter.com/OviyaMedSafe
LinkedIn: www.linkedin.com/company/oviya-medsafe

News & Events

View All